Snowden Capital Advisors LLC Moderna, Inc. Transaction History

Snowden Capital Advisors LLC

$3.31 Billion
Q2 2024

A detailed history of Snowden Capital Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 2,897 shares of MRNA stock, worth $190,477. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,897

Previous 2,552 13.52%

Holding current value

$190,477

Previous $271,000 26.94%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $34,917 - $57,480	345 Added 13.52%	2,897 $344,000
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $217,864 - $294,602	2,552 New	2,552 $271,000
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $18,130 - $24,561	153 Added 5.0%	3,210 $390,000
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $58,740 - $85,309	433 Added 16.5%	3,057 $469,000
Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $73,513 - $130,434	-621 Reduced 19.14%	2,624 $471,000
Q3 2022 Nov 09, 2022	SELL	$118.07 - $194.18 $37,310 - $61,360	-316 Reduced 8.87%	3,245 $383,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $184,948 - $278,835	-1,579 Reduced 30.72%	3,561 $508,000
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $318,426 - $591,855	2,518 Added 96.03%	5,140 $885,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $592,100 - $966,233	2,622 New	2,622 $665,000
Q3 2021 Feb 05, 2024	BUY	$221.9 - $484.47 $760,229 - $1.66 Million	3,426 New	3,426 $1.32 Billion
Q2 2021 Jan 08, 2024	BUY	$129.91 - $234.98 $6,495 - $11,749	50 Added 1.48%	3,420 $804 Million
Q1 2021 Jan 08, 2024	BUY	$109.18 - $185.98 $11,463 - $19,527	105 Added 3.22%	3,370 $441 Million
Q4 2020 Jan 08, 2024	SELL	$65.74 - $169.86 $49,173 - $127,055	-748 Reduced 18.64%	3,265 $341 Million
Q3 2020 Jan 08, 2024	BUY	$54.34 - $94.85 $218,066 - $380,633	4,013 New	4,013 $284 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Account

Snowden Capital Advisors LLC Moderna, Inc. Transaction History